TCT 525: Cutting Balloon versus Standard Balloon for Lesion Preparation of Drug-Coated Balloon Treatment in De-novo Coronary Artery Lesions: Primary Endpoint of the Randomized NATURE Trial Receive the ...
Please provide your email address to receive an email when new articles are posted on . The Integra-D trial evaluated a novel implantable cardiac contractility modulation defibrillator for its ability ...
MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...
The autonomic nervous system (ANS) is pivotal in maintaining cardiac homeostasis, intricately regulating heart rate, contractility, and vascular tone through its sympathetic and parasympathetic ...
MINNEAPOLIS, MN—A novel implantable device that provides both cardiac contractility modulation as well as defibrillation (CCM-D) successfully and safely delivers integrated therapy, while also ...
The U.S. Centers for Medicare & Medicaid Services (CMS) has issued a draft coverage memo for cardiac contractility modulation (CCM), which offers coverage with evidence development for the company’s ...
Effects of a Novel Cardiac Contractility Modulation-Defibrillator (CCM-D) on NYHA Functional Class in ICD-Indicated Patients: Post-Implant Results from the Integra-D Trial Late Breaking Clinical ...
Impulse Dynamics Inc. snared an affirmative Medicare coverage policy for its Optimizer cardiac contractility modulation (CCM) system, giving the company sole possession of the U.S. marketplace for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results